Clinical trial

IP3R Modulation by Cancer Genes in Mesothelioma

NCT03558932

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2019-01-01

PhaseN/A

Study timeline

Study start (estimated)2019-01-01Date precision: month

Registry last updated2018-06-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Malignant Mesotheliomaunresolved

Interventions

pleural biopsyDIAGNOSTIC_TEST

Sponsors & collaborators

KU Leuvenlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03558932 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.